A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer.
Saved in:
| Title: | A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer. |
|---|---|
| Authors: | Murphy AG; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Zahurak M; Department of Oncology, Biostatistics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Shah M; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Weekes CD; University of Colorado, Boulder, Colorado, USA., Hansen A; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Siu LL; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Spreafico A; Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada., LoConte N; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, USA., Anders NM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Analytical Pharmacology Core, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Miles T; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Rudek MA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Analytical Pharmacology Core, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.; Division of Clinical Pharmacology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA., Doyle LA; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA., Nelkin B; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Maitra A; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Azad NS; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. |
| Corporate Authors: | ETCTN-9231 Study Team |
| Source: | Clinical and translational science [Clin Transl Sci] 2020 Nov; Vol. 13 (6), pp. 1178-1188. Date of Electronic Publication: 2020 Aug 01. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1752-8062 |
|---|---|
| DOI: | 10.1111/cts.12802 |
